These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16870257

  • 21. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG, Mangueira CL, Cruz LA, Cruz CM.
    Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
    [Abstract] [Full Text] [Related]

  • 22. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M, Bigler C, Danner D, Ditzel HJ, Trendelenburg M.
    J Immunol; 2009 Dec 15; 183(12):8225-31. PubMed ID: 20007586
    [Abstract] [Full Text] [Related]

  • 23. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM, Eesa NN, Yacoub MH, Elsman RM.
    Adv Rheumatol; 2019 Mar 04; 59(1):10. PubMed ID: 30832710
    [Abstract] [Full Text] [Related]

  • 24. Pathogenesis of lupus nephritis: an update.
    Tang S, Lui SL, Lai KN.
    Nephrology (Carlton); 2005 Apr 04; 10(2):174-9. PubMed ID: 15877678
    [Abstract] [Full Text] [Related]

  • 25. Anti-C1q autoantibodies.
    Kallenberg CG.
    Autoimmun Rev; 2008 Sep 04; 7(8):612-5. PubMed ID: 18606253
    [Abstract] [Full Text] [Related]

  • 26. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y, Yang XW, Song Y, Yu F, Zhao MH.
    Immunobiology; 2014 Dec 04; 219(12):980-9. PubMed ID: 25092568
    [Abstract] [Full Text] [Related]

  • 27. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S, Vanhecke D, Trendelenburg M.
    Clin Immunol; 2015 Oct 04; 160(2):180-7. PubMed ID: 26148903
    [Abstract] [Full Text] [Related]

  • 28. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P.
    J Rheumatol; 2006 Apr 04; 33(4):695-7. PubMed ID: 16583471
    [Abstract] [Full Text] [Related]

  • 29. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
    Tsanyan ME, Torgashina AV, Aleksandrova EN, Soloviev SK, Nasonov EL.
    Ter Arkh; 2013 Apr 04; 85(5):53-9. PubMed ID: 23819340
    [Abstract] [Full Text] [Related]

  • 30. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.
    O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR.
    Mol Immunol; 2011 Oct 04; 49(1-2):75-83. PubMed ID: 21855148
    [Abstract] [Full Text] [Related]

  • 31. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH.
    Egypt J Immunol; 2014 Oct 04; 21(2):49-59. PubMed ID: 25812352
    [Abstract] [Full Text] [Related]

  • 32. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N, Khoshmirsafa M, Shekarabi M, Falak R, Haghighi A, Masoodian M, Seif F, Omidi F, Shirani F, Dadfar N.
    J Immunoassay Immunochem; 2021 Jul 04; 42(4):406-423. PubMed ID: 33788670
    [Abstract] [Full Text] [Related]

  • 33. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D.
    Immunobiology; 2012 Jul 04; 217(7):684-91. PubMed ID: 22209113
    [Abstract] [Full Text] [Related]

  • 34. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
    Cai X, Yang X, Lian F, Lin X, Liang M, Li J, Chen X, Liang L, Qin S, Fu J.
    J Rheumatol; 2010 Apr 04; 37(4):759-65. PubMed ID: 20194446
    [Abstract] [Full Text] [Related]

  • 35. C1q and systemic lupus erythematosus.
    Walport MJ, Davies KA, Botto M.
    Immunobiology; 1998 Aug 04; 199(2):265-85. PubMed ID: 9777411
    [Abstract] [Full Text] [Related]

  • 36. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C, Hopfer H, Danner D, Schaller M, Mihatsch MJ, Trendelenburg M.
    Nephrol Dial Transplant; 2011 Apr 04; 26(4):1220-8. PubMed ID: 20841491
    [Abstract] [Full Text] [Related]

  • 37. Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.
    Bruschi M, Galetti M, Sinico RA, Moroni G, Bonanni A, Radice A, Tincani A, Pratesi F, Migliorini P, Murtas C, Franceschini F, Trezzi B, Brunini F, Gatti R, Tardanico R, Barbano G, Piaggio G, Messa P, Ravani P, Scolari F, Candiano G, Martini A, Allegri L, Ghiggeri GM.
    J Am Soc Nephrol; 2015 Aug 04; 26(8):1905-24. PubMed ID: 25398787
    [Abstract] [Full Text] [Related]

  • 38. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M.
    J Immunol; 2009 Sep 01; 183(5):3512-21. PubMed ID: 19648280
    [Abstract] [Full Text] [Related]

  • 39. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC, Wang CR, Liu MF, Chen FF, Liang CC.
    Asian Pac J Allergy Immunol; 2002 Dec 01; 20(4):223-7. PubMed ID: 12744622
    [Abstract] [Full Text] [Related]

  • 40. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA, Trouw LA, Daha MR.
    Curr Opin Nephrol Hypertens; 2003 Nov 01; 12(6):619-24. PubMed ID: 14564199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.